Michael Scolaro

Michael Scolaro

Oct 30, 2017

Group 6 Copy 230
4
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Are climate change and air pollution triggering cardiovascular disease?

Ongoing global climate change and air pollution emissions pose a major threat to cardiovascular health...

Can we noninvasively measure blood sugar for diabetes?

Better management of type 1 diabetes is moving towards anartificial pancreas. However, we need a better...

Fancy footwork: How different are the feet of zoo and wild giraffe?

Cooperative training helps zookeepers care for zoo animals. For giraffe, much of this training focuses on...

Backer Badge Funded